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Abstract
Background: Because frailty is a complex phenomenon associated with poor outcomes, the identification of patient profiles with different 
care needs might be of greater practical help than to look for a unifying definition. This study aimed at identifying aging phenotypes and their 
related outcomes in order to recognize frailty in hospitalized older patients.
Methods: Patients aged 65 or older enrolled in internal medicine and geriatric wards participating in the REPOSI registry. Relationships among 
variables associated to sociodemographic, physical, cognitive, functional, and medical status were explored using a multiple correspondence 
analysis. The hierarchical cluster analysis was then performed to identify possible patient profiles. Multivariable logistic regression was used 
to verify the association between clusters and outcomes (in-hospital mortality and 3-month postdischarge mortality and rehospitalization).
Results: 2,841 patients were included in the statistical analyses. Four clusters were identified: the healthiest (I); those with multimorbidity 
(II); the functionally independent women with osteoporosis and arthritis (III); and the functionally dependent oldest old patients with 
cognitive impairment (IV). There was a significantly higher in-hospital mortality in Cluster II (odds ratio [OR]  =  2.27, 95% confidence 
interval [CI] = 1.15–4.46) and Cluster IV (OR = 5.15, 95% CI = 2.58–10.26) and a higher 3-month mortality in Cluster II (OR = 1.66, 95% 
CI = 1.13–2.44) and Cluster IV (OR = 1.86, 95% CI = 1.15–3.00) than in Cluster I.
Conclusions: Using alternative analytical techniques among hospitalized older patients, we could distinguish different frailty phenotypes, differently 
associated with adverse events. The identification of different patient profiles can help defining the best care strategy according to specific patient needs.
Keywords: Frailty—Aging phenotypes—Outcomes—Internal medicine and geriatric wards—Cluster analysis
Frailty has been conceptualized as a state of late-life decline and vul-
nerability due to a reduced ability to adapt to stressors (eg, acute 
illness) and is associated with an increased risk of adverse health 
outcomes and death (1–3). Different definitions of frailty have been 
proposed in the scientific literature to help clinicians, researchers, 
and other stakeholders. The most commonly used is the physi-
cal frailty phenotype by Fried and colleagues, which is based on 
criteria related to reduced physical reserves (weight loss, exhaus-
tion, weakness, slowness, and reduced physical activity) (1). Other 
definitions, for example, the Frailty Index (4), the Clinical Frailty 
Scale (5), the Groningen or Tilburg Frailty Indicator (6,7), and the 
Edmonton Frail Scale (8) include additional deficits concerning dif-
ferent domains, such as cognition and mood, organ diseases, phar-
macotherapy, functional autonomy, and social conditions. Most of 
the existing frailty tools have been developed and validated in the 
frame of community-dwelling older adults; only few studies were 
specifically oriented to predict the outcomes of hospitalized older 
people (9,10). When applied to the same population, the different 
existing definitions overlapped only partially in the identification of 
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outcomes (10–14). Because frailty does not identify a specific dis-
ease but is a complex phenomenon with a multifactorial etiology, 
it is likely that a diagnostic gold standard does not exist. Thus the 
identification of different frailty profiles with the associated differ-
ent care needs might be of greater practical help than to look for a 
unifying definition, in order to better manage frail people. With this 
background, we analyzed data from the REPOSI registry on hos-
pitalized older patients with the aims (i) to identify patient profiles 
providing features that describe homogeneous subsets of patients 
on the basis of clinically relevant variables available in the registry 
(ie, lifestyle, physical and cognitive status, functional performance, 
comorbidities, and medications) and (ii) to study the association of 
the identified phenotypes with clinical outcomes (in-hospital mortal-
ity, 3-month postdischarge mortality, and rehospitalization).
Methods
Setting and Participants
The present study is based on data prospectively collected in the 
frame of the REPOSI project. REPOSI (REgistro POliterapie SIMI) 
is an ongoing collaboration between the Italian Society of Internal 
medicine (SIMI), the IRCCS—Istituto di Ricerche Farmacologiche 
“Mario Negri,” and Fondazione IRCCS Ca’ Granda Ospedale 
Maggiore Policlinico of Milan, launched in 2008 with the aim to 
investigate various aspects related to multimorbidity and polyp-
harmacy in an older acutely hospitalized population. REPOSI is a 
multicenter prospective registry designed to collect information on 
patients aged 65 or older, consecutively admitted to internal medi-
cine or geriatric wards of Italian hospitals during 4 index weeks 
(one for each season). Since 2014, Spanish hospitals also partici-
pated in the data collection. A standardized web-based case report 
form, with detailed instructions for the compilation, was provided 
to the attending physicians. Specifically, a detailed explanation on 
how to fill geriatric scales has been also introduced in order to 
improve the standardization of the compilation at different times 
and among several centers (internal medicine and geriatric wards). 
Moreover, a clinical monitor dedicated to the project was always 
available to support physicians during the compilation of case 
report form. The principal data collected include sociodemographic 
factors, clinical and laboratory data, and pharmacological thera-
pies. After discharge, additional follow-up data were collected via 
telephone calls at 3  months. Participation was voluntary, and all 
participants signed an informed consent. More detailed description 
of the data set is available in reference (15). For the purpose of 
this study, data collected in 2010, 2012, and 2014 were analyzed 
because postdischarge follow-up data were added to the REPOSI 
data set only since 2010.
The REPOSI project was approved by the local ethical commit-
tees of the participating centers.
Variables
The authors prespecified a list of variables that are usually included 
in the assessment of frailty (4) and looked for those available in the 
REPOSI registry. In addition, they considered those variables that 
they considered to be related to an unhealthy condition and avail-
able in the frame of hospitalized patients. The retrieved variables 
considered for the analyses were grouped as follows:
• Sociodemographic, anthropometric, and lifestyle data: sex, 
age, body mass index, living condition, smoke, and alcohol 
consumption.
• Medical history data (at admission) collected according to the 
Cumulative Illness Rating Scale (CIRS) (16); in particular, pres-
ence of hypertension, diabetes, ischemic heart diseases, chronic 
obstructive pulmonary disease, chronic kidney disease, heart 
failure, arthropathies and dorsopathies (here named arthritis), 
neoplasm, osteoporosis (including also fractures and prosthesis), 
liver diseases, thyroid disorders, depression (excluding bipolar 
disorders), dementia, sensorial deficits (including hearing and 
visual impairment); hospitalization during the 6 months preced-
ing the index admission; number of diagnoses and drugs.
• Functional status: performance in activities of daily living meas-
ured by the Barthel Index (17).
• Cognition and mood: the Short Blessed Test (SBT) (18) and the 
4-item Geriatric Depression Scale (GDS-4) (19).
• Clinical and laboratory parameters (at admission): systolic blood 
pressure, heart rate, mean corpuscular volume, total cholesterol, 
hemoglobin, and estimated creatinine clearance according to the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 
formula (20).
Statistical Analysis
Exploring the relationships between variables
Multiple correspondence analysis (MCA) (21) was performed in 
order to study the relationships between categorical variables. MCA 
is an explorative multivariate statistical technique that allows to 
summarize the information contained in a large amount of origi-
nally related variables into a small set of unrelated variables, named 
factorial axes. Results of MCA can be graphically represented on 
the plane identified by the factorial axes. Original categories are rep-
resented on the plane as points with specific coordinates on each 
axis to form clouds of categories, with the distance between points 
providing an approximate description of the association/relationship 
among categories. Also, a cloud of individuals can be represented 
using coordinates on the newly identified factorial axes, so that 
patients with similar coordinates share similar profiles.
More details are provided in Supplementary Material.
Identification of possible frailty profiles
In order to identify patient profiles potentially related to a frailty 
condition, an agglomerative hierarchical cluster analysis (HCA) was 
performed. Clustering techniques allow to classify patients within 
homogeneous subsets (clusters) through the definition of a distance 
between individuals on the basis of their characteristics. The score 
(coordinates) obtained on the first three factorial axes identified 
through the MCA was used to calculate distances (22). The stability 
of the clusters identified through the HCA (ie, internal validation) 
was investigated by means of resampling methods (bootstrap). The 
similarity between each clustering procedure on the resample data 
and that on the original data was assessed via the Jaccard’s coef-
ficient (23). To this aim 1,000 bootstrap resamples with replacement 
were randomly generated from the original data. Each participant 
was then assigned to the cluster in which it was most frequently 
classified. MCA and HCA were performed on a complete case basis.
Association of clusters with adverse outcomes
Multivariable logistic regression analysis was used to evaluate the 
association among the identified clusters and outcomes (in-hospital 
and 3-month mortality and rehospitalizations), adjusting by the 
country (Spain vs Italy) and type of ward (geriatric vs internal medi-
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Version 9.4 (SAS Institute, Cary, NC) and R (R Development Core 
Team, 2006), with FactoMineR and ca packages added.
Results
Study Population
Globally 3,915 patients, hospitalized in 116 internal medicine and 
geriatric wards (15 from Spain), were enrolled in the REPOSI registry 
in years 2010 (N = 1,380), 2012 (N = 1,323), and 2014 (N = 1,212). 
Less than 5% of patients were enrolled in Spanish hospital wards. 
The flow diagram of patients included in the study is reported in 
Supplementary Figure 1. Patient characteristics at hospital admission 
are given in Table 1.
Of the patients enrolled, 50% were women; their mean age was 
78.7 years (SD = 7.4). According to body mass index cutoffs, 978 
(27.7%) patients were underweight and 1,278 (36.2%) were over-
weight or obese. Most of the patients presented a good degree of 
independence according to the Barthel Index (47.1%). The most 
frequent morbidities were hypertension (76.5%), diabetes (28.6%), 
and heart diseases (24.7%). According to the SBT, almost half of the 
patients (44.5%) had a moderate-to-severe cognitive impairment. 
Overall 2,348 patients (60.0%) were on polypharmacy (≥5 drugs).
The complete case sample was represented by 2,841 patients 
who were finally included in the MCA and HCA analyses.
Multiple Correspondence Analysis
In a preliminary analysis, the following variables carrying a neg-
ligible contribution in the explanation of the factorial axes were 
discarded: systolic blood pressure, heart rate, mean corpuscular vol-
ume, neoplasm, depression, sensorial deficits, total cholesterol, liver, 
Table 1. Sociodemographic, Clinical, and Laboratory Characteristics at Hospital Admission of 3,915 Patients Enrolled in REPOSI Registry
Variables No. (%) Missing (No.)
Year
 2010 1,380 (35.2)
 2012 1,323 (33.8)
 2014 1,212 (31.0)
Country
 Italy 3,746 (95.7)
 Spain 169 (4.3)
Sex
 Male 1,956 (50.0)
 Female 1,959 (50.0)
Age, mean (SD) 78.7 (7.4)
 Young old (65–75 years) 1,380 (35.2)
 Middle old (76–84 years) 1,603 (41.0)
 Oldest old (≥85 years) 932 (23.8)
Body mass index, mean (SD) 25.9 (5.1) 385
 Underweight (<23 kg/m2) 978 (27.7)
 Normal weight (≥23 kg/m2) 1,274 (36.1)
 Overweight (≥27 kg/m2) 661 (18.7)
 Obese (≥30 kg/m2) 617(17.5)
Living arrangement 137
 Alone 831 (22.0)
 With relatives 2,508 (66.4)
 Others (caregiver) 206 (5.4)
 Nursing home 233 (6.2)
Alcohol intake 102
 Never 1,829 (48.0)
 Former drinker 288 (7.5)
 Drinker 737 (19.3)
 Occasional drinker 959 (25.2)
Smoke 94
 No 2,068 (54.1)
 Former smoker 1,422 (37.2)
 Yes 331 (8.7)
Barthel Indexa 64
 No or negligible dependence (91–100) 1,815 (47.1)
 Mild dependence (75–90) 675 (17.6)
 Moderate dependence (50–74) 494 (12.8)
 Severe dependence (25–49) 352 (9.1)
 Total dependence (0–24) 515 (13.4)
Short Blessed Test 355
 Normal (0–4) 1,348 (37.9)
 Possible cognitive impairment (5–9) 628 (17.6)
 Moderate cognitive impairment (10–19) 1,135 (31.9)
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and thyroid disorders. Thus, values concerning 23 variables were 
used. The CIRS-CI and CIRS-SI were not used to assess MCA solu-
tion; however, they were plotted on the cloud of categories (sup-
plementary variables—see Supplementary Material). The first three 
factorial axes in the MCA explained almost 71% of the overall 
variability in the data and were used to calculate the distances in the 
subsequent HCA.
Supplementary Figure 2 shows the resulting cloud of categories 
projected on the plane defined by the first and second factorial axes 
and Supplementary Figure 3 the cloud of categories projected on the 
plane defined by the second and third axes with detailed description. 
Briefly, according to the configuration of the cloud of categories, the 
first axis could be interpreted as the expression of the burden of 
disease, the second axis as the expression of musculoskeletal and 
cognitive morbidity, and the third axis as the expression of cognitive 
deterioration and functional dependence.
Hierarchical Cluster Analysis
HCA, performed on the scores of the first three components, identi-
fied four main clusters of patients. The Bootstrap showed a quite 
good stability of results (the four means of all Jaccard’s coefficients 
were about 0.87). Figure  1 represents the cloud of individuals, 
Variables No. (%) Missing (No.)
Geriatric Depression Scale 585
 Normal (0–1) 1,923 (57.7)
 Probable depression (2–4) 1,407 (42.3)
Hemoglobinb 17
 No anemia 1,704 (43.7)
 Mild anemia 922 (23.6)
 Moderate anemia 1,055(27.1)
 Severe anemia 217 (5.6)
Creatinine clearance 40
 Stage I (>90) 399 (10.3)
 Stage II (≤90) 1,587 (41.0)
 Stage III (≤60) 1,384 (35.7)
 Stage IV (≤30) 373 (9.6)
 Stage V (≤15) 132 (3.4)
Number of drugs
 0 123 (3.1)
 1 206 (5.3)
 2–4 1,238 (31.6)
 5–9 1,931 (49.3)
 ≥10 417 (10.7)
Previous hospital admissions 1,271 (32.5)
Number of diagnoses
 0–4 1,432 (36.6)
 ≥5 2,483 (63.4)
CIRS—Severity Index, median (IQR) 1.6 (1.4–1.8) 45
 <1.4 1,006 (26.0)
 ≥1.4 717 (18.5)
 ≥1.6 999 (25.8)
 ≥1.8 1,148 (29.7)
CIRS—Comorbidity Index, median (IQR) 3 (2–4) 45
 0 282 (7.3)
 1–3 2,152 (55.6)
 >3 1,436 (37.1)
Diagnosis
 Hypertension 2,984 (76.5)
 Diabetes mellitus 1,107 (28.6)
 Ischemic heart diseases 957 (24.7)
 Chronic obstructive pulmonary disease 702 (18.1)
 Chronic kidney disease 698 (18.0)
 Heart failure 696 (18.0)
 Arthritis 647 (16.7)
 Osteoporosis 531 (13.7)
 Dementia 397 (10.2)
Notes: CIRS = Cumulative Illness Rating Scale; IQR = interquartile range; SD = standard deviation.
aEvaluated during hospital stay.
bNo anemia (male: ≥13 g/dL; female: ≥12 g/dL); mild anemia (male: ≥11 g/dL and <13 g/dL; female: ≥11 g/dL and <12 g/dL); moderate anemia (male and female: 
≥8 g/dL and <11g/dL); severe anemia (male and female: <8 g/dL). Hypertension (ICD-9: 401–405); chronic kidney disease (ICD-9: 585); diabetes mellitus (ICD-9: 
250); chronic obstructive pulmonary disease (ICD-9: 4912); heart failure (ICD-9: 428); dementia (ICD-9: 290 / 294 / 310 / 331); osteoporosis (ICD-9: 733) in-
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according to cluster distribution, projected on the plane defined by 
the first and the second factorial axes (upper panel) and that identi-
fied by the second and the third factorial axes (lower panel). The dis-
tribution of patients’ characteristics within each cluster is reported 
in Supplementary Table 1.
As Supplementary Table 1 shows, Cluster I (924 patients), mainly 
associated with negative scores of the first axis, included the healthi-
est individuals, mainly young old men with low prevalence of severe 
diseases and less frequently on polypharmacy (patients with healthy 
phenotype). Cluster II (791), mostly associated with negative scores 
of the second axis, included patients, mostly men (87.5%), with a 
severe multimorbidity profile (ie, severe cardiovascular, pulmonary, 
and renal diseases) and on polypharmacy (90.3%) (men with mul-
timorbidity phenotype). Cluster III (785), associated with negative 
scores of the third axis, was largely represented by middle old women 
(94.5%) functionally independent in their daily activities (near 42% 
of them lived alone and 47% had a BI > 91) and characterized by a 
healthy lifestyle (74% never drank and 88% never smoked). Almost 
half of patients with a diagnosis of osteoporosis and arthritis (data 
not shown) are included in this cluster (independent women with 
musculoskeletal involvement phenotype). Overweight and obese 
individuals were mostly included in Clusters II and III (68.9%). 
Cluster IV (341), associated with positive scores of the second and 
third axes, was composed of the oldest patients, mostly women 
(65%), with increasing cognitive impairment and severe-to-total 
dependence. The underweight condition was highly prevalent in this 
cluster (42.8%). The majority of patients with a diagnosis of demen-
tia (78.6%—data not shown) were included in this cluster (depend-
ent patients with cognitive deterioration phenotype).
Association With Outcomes
Among the 2,841 patients included in the analyses, for 15 it was not 
known whether they were discharged alive, so that 2,826 were assess-
able. Table 2 shows the prevalence of adverse outcomes (in-hospital 
mortality, 3-month mortality, and rehospitalization) and the length of 
hospital stay within each cluster. Globally 71 (2.5%) patients died dur-
ing the hospital stay (Supplementary Figure 1). Among 2,008 patients 
with available follow-up, 181 (9.0%) died within 3  months from 
discharge. During the 3 months after discharge, overall 552 patients 
(27.5%) were rehospitalized at least once. Table 3 reports the results 
of multivariable logistic regression models. There were a significantly 
higher in-hospital and 3-month mortality in Cluster II and Cluster 
IV with respect to Cluster I. A higher 3-month mortality was found 
in Spanish patients. No statistically significant association was found 
between cluster classification and rehospitalization, but patients in 
Cluster II had a slightly higher risk of being rehospitalized than those 
in Cluster I (odds ratio 1.33, 95% confidence interval 1.00–1.76). The 
type of ward was not associated with adverse outcomes.
Figure 1. Results from hierarchical cluster analysis: the cloud of individuals according to clusters. (Upper panel) The cloud is plotted on the plane determined by 
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Discussion
Main Study Findings
Using alternative analytical techniques, we explored the relation-
ships between commonly and easily assessable variables potentially 
related to the frailty syndrome in older hospitalized people, and we 
were able to identify four distinct clusters of patients. Two of these 
clusters were likely related to a frailty condition, but with different 
characteristics: The first was mainly composed of middle old men 
affected by multiple chronic diseases (men with multimorbidity phe-
notype) and the second one by the oldest patients, mostly women, 
with severe cognitive decline and loss of independence (dependent 
patients with cognitive deterioration phenotype). On the other end, 
we identified a cluster of healthier individuals with a low prevalence 
of multimorbidity and polypharmacy (patients with healthy pheno-
type). Finally, we identified a fourth cluster composed of middle old 
women, with the highest prevalence of osteoporosis, arthritis, and 
related complications (eg, fractures and replacement interventions) 
but with no significant functional impairment (independent women 
with musculoskeletal involvement phenotype), often affected by 
cardiovascular and metabolic morbidities. Our results confirmed an 
association of the former two clusters with adverse outcomes (in-
hospital or 3-month mortality), being the patients with cognitive 
deterioration phenotype those with the highest in-hospital mortal-
ity. The patients with the multimorbidity phenotype had a slightly 
higher risk of rehospitalization, although not statistically significant.
Interpretation and Practical Implications
Although the physical frailty phenotype has received a wider consen-
sus by the scientific community (24), some studies demonstrated that 
a definition of frailty encompassing a broader spectrum of deficits 
(such as comorbidities and cognitive and mood decline) could pre-
dict the susceptibility to adverse outcomes with higher discrimina-
tion than a definition limited only to physical dysfunction (25,26).
A previous study showed that measuring frailty in older people 
admitted to emergency departments for minor injuries helps to screen 
those at risk of functional decline (27). Thus the characterization of 
the clinical phenotype among older adults acutely admitted to the 
hospital (internal medicine and geriatric wards) and their stratifica-
tion according to their risk profile that we propose here could have 
important implications. It provides clinicians with a useful tool for 
the stratification of patients on the basis of their specific needs and/
or the screening of patients at risk of frailty with implication on 
their diagnostic and therapeutic management. Indeed, besides the 
two phenotypes related to frailty conditions and characterized by a 
higher risk of adverse outcomes, we identified one cluster of middle 
old women that, although not associated with a higher incidence 
of adverse outcomes, could be seen as prefrail, as suggested by the 
musculoskeletal involvement and the higher prevalence of cardiovas-
cular (87.5% of hypertension and 19.7% of ischemic heart disease) 
and metabolic diseases (29.9% of diabetes). Previous findings estab-
lished that declines in executive functioning are associated with risk 
of frailty onset (28,29) In our study population, the rehospitalization 
rates within 3 months from discharge were on average high (about 
20%) in all four clusters. From a public health perspective, the high 
prevalence of early rehospitalization even in the healthiest individu-
als from Cluster I points out, on one side, the frequent inadequacy 
of hospital referrals and of the corresponding response from a care 
setting such as the hospital. Hospitals indeed are traditionally organ-
ized as services for the provision of acute cares to organ diseases and 
not for the management of needs involving the cognitive domain 
and function. Thus our findings point out the need of a better imple-
mentation and integration of social and health care assistance of 
these patients outside the hospital, in order to improve the postacute 
phase after hospital discharge, prevent rehospitalization, and delay 
the progression of frailty.
Limitations and Strengths
The large number of participating centers and their allocation 
through all Italy and Spain make the study representative of the 
overall Italian and Spanish settings of internal medicine and geriat-
ric wards, even if the latter were less in number. Being the REPOSI 
a multicenter registry based on voluntary work, missing data are 
one of the main limitations of the analyses. The assessment of 
anthropometric and laboratory parameters (eg, body mass index 
and cholesterol) and geriatric scales (eg, SBT, GDS, and BI) was 
Table 3. Results of Multivariable Logistic Regression Models for In-hospital and 3-Month Mortality
In-hospital Mortality 3-Month Mortality
OR (95% CI) OR (95% CI)
Cluster I Reference Reference
Cluster II 2.27 (1.15–4.46) 1.66 (1.13–2.44)
Cluster III 0.79 (0.34–1.87) 0.60 (0.37–0.96)
Cluster IV 5.15 (2.58–10.26) 1.86 (1.15–3.00)
Country (Spain vs Italy) 1.79 (0.63–5.14) 3.39 (1.71–6.70)
Note: CI = confidence interval; OR = odd ratio.
Table 2. Prevalence of Adverse Outcomes and Length of Hospital Stay Within Each Cluster
Cluster I N = 924 Cluster II N = 791 Cluster III N = 785 Cluster IV N = 341
In-hospital mortality, n (%) 13 (1.4) 25 (3.2) 9 (1.2) 24 (7.1)
3-Month mortality, n (%) 49 (7.8) 71 (12.4) 29 (5.0) 32 (14.2)
3-Month rehospitalization, n (%) 121 (19.4) 137 (24.3) 122 (21.1) 465 (20.7)
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not mandatory at hospital admission, especially during short-term 
hospitalization. This could partially explain the large amount of 
missing data for those variables. Comparing the overall population 
and that included in the analyses, only small differences are noted 
and none that could be considered clinically significant. Thus miss-
ing data have limited impact on the selection of patients included 
in the analyses. Any difference among Spanish and Italian patients 
were reflected in the different composition of patient nationality 
included within each cluster (see Supplementary Table  1). Some 
possibly relevant variables were either not included (eg, data on 
the economic status and physical performance) or expected to be 
underreported (eg, data on hearing and visual impairment and on 
diagnosis of depression, osteoporosis, dementia, falls, and bed-
sores). This represents certainly a limitation in the attempt to char-
acterize such a complex phenomenon, as the frailty syndrome, and 
precludes the possibility to make a comparison with other indica-
tors. On the other hand, most of considered variables were com-
monly available and easily assessable in daily clinical practice by 
physicians and other stakeholders. Second, we could not explore 
the association between phenotypes and the risk of adverse events 
over a longer time. However, the well-known high rate of short-
term adverse event occurring after the hospital admission of an 
old person (30) makes them a priority of the management plan. 
Finally, our results were obtained from a hospitalized older cohort 
so that, although they showed a good degree of stability—internal 
validation—as proven by the Bootstrap, their generalizability to 
other settings (ie, community-dwelling people and nursing home 
residents) should be investigated.
Conclusions
Assessing for frailty at hospital admission has been compared with 
“predicting speed at traffic lights,” and its clinical utility has been 
debated if the information on how and how much the patient sta-
tus had changed over a certain time before the admission is lack-
ing (31). However, it is well known that hospitalization per se 
represents an accelerating event, a critical turning point at which 
the slope, whatever the trajectory is, becomes sharper (30,32). 
Therefore, it is especially in the setting of older inpatients, among 
whom the chance of adverse events is high, that the identification 
of different patient profiles, rather than the distinction between 
those at risk and those not at risk, can help to define the best man-
agement according to specific patient needs. This could be helpful 
both for the clinician and for those involved in the organization of 
care provision.
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